Reaction equation
[Cl:1][C:2]1[C:7]([F:8])=[C:6]([Cl:9])[CH:5]=[CH:4][C:3]=1[C:10]([N:12]1[CH2:17][CH2:16][NH:15][C:14](=O)[CH2:13]1)=[O:11].F[B-](F)(F)F.C([O+](CC)CC)C.[N:31]1[CH:36]=[CH:35][N:34]=[CH:33][C:32]=1[C:37]([NH:39][NH2:40])=O>ClCCl>[Cl:1][C:2]1[C:7]([F:8])=[C:6]([Cl:9])[CH:5]=[CH:4][C:3]=1[C:10]([N:12]1[CH2:17][CH2:16][N:15]2[C:37]([C:32]3[CH:33]=[N:34][CH:35]=[CH:36][N:31]=3)=[N:39][N:40]=[C:14]2[CH2:13]1)=[O:11]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-[(2,4-dichloro-3-fluorophenyl)carbonyl]-2-piperazinone (I37) (0.146 g, 0.5 mmol) in Dichloromethane (DCM) (3 mL) was added triethyloxonium tetrafluoroborate (0.100 g, 0.525 mmol). The solution was then stirred, under argon, for 10 minutes before 2-pyrazinecarbohydrazide (commercially available from e.g. TimTec, J& W PharmLab and Akos Consulting, 0.083 g, 0.600 mmol) was added. The solution was then stirred for a further hour before the solvent was concentrated and n-butanol (3.00 mL) was added. The solution was then stirred, under argon and reflux, for 3 hours before being cooled to room temperature. The solvent was then evaporated in vacuo and the remaining residue was purified by flash chromatography (Biotage SP4, 25M cartridge) with a gradient of 0-10% 2M NH3/MeOH in DCM. TLC confirmed product location and the solvent from the combined fractions was evaporated in vacuo. The remaining residue was then further purified by mass-direct automated HPLC, before the solvent was again evaporated in vacuo. The remaining solid was then triturated in ether before being dried in a vac-oven to yield the product in 0.056 g.
Workup
- additionwas added
- concentrationwas concentrated
- additionn-butanol (3.00 mL) was added
- stirringThe solution was then stirred, under argon
- temperaturereflux, for 3 hours
- customThe solvent was then evaporated in vacuo
- customthe remaining residue was purified by flash chromatography (Biotage SP4, 25M cartridge) with a gradient of 0-10% 2M NH3/MeOH in DCM
- customthe solvent from the combined fractions was evaporated in vacuo
- customThe remaining residue was then further purified by mass-direct automated HPLC, before the solvent
- customwas again evaporated in vacuo
- customThe remaining solid was then triturated in ether
- custombefore being dried in a vac-oven
- customto yield the product in 0.056 g
Sources & evidence
- ORD record
- ord-3b6d521a11e841ac989f192d4d123ed4
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08501946B2
Linked notes
Loading…